Tag Archives: breast cancer drug

A group of prominent cancer doctors is planning a novel assault on high drug costs, using clinical trials to show that many oncology medications could be taken at lower doses or for shorter periods without hurting their effectiveness, in this … Continue reading

Posted in Chemotherapy, Clinical Trials, Doctor-Patient Relationship, Information Strength, Research News, We Live You®: The Latest | Tagged , , , | Comments Off

A promising new compound appears to impede a process that fuels breast cancer in mice, a discovery that could have implications in the treatment of a host of cancers, as discussed in this release from Ohio State University. On top … Continue reading

Posted in Chemotherapy, Information Strength, Research News, We Live You®: The Latest | Tagged , , , | Comments Off

Last month, the Journal of Clinical Oncology reported that six chemotherapy regimens commonly given to patients with early-stage breast cancer vary widely in their side effects. Researchers found that some drug combinations are more likely to lead to hospitalization than … Continue reading

Posted in Chemotherapy, Dr. Jay Harness Expertise, Emotional Reconstruction®, Information Strength, Newly diagnosed breast cancer, Research News, We Live You®: The Latest | Tagged | Comments Off

Doctors are calling the approval of a drug called Perjeta by a Food and Drug Administration advisory panel a historic moment in breast cancer treatment. The panel is approving the medication to shrink tumors before surgery in early-stage patients, according … Continue reading

Posted in Breast Cancer Surgery, Chemotherapy, Clinical Trials, Dr. Jay Harness Expertise, Information Strength, Research News, Video, We Live You®: The Latest | Tagged , | Comments Off

It’s old news that aspirin can reduce cancer risk, but a new study conducted at the University of Oxford suggests a daily 75 mg dose of aspirin may also stop the spread of cancer in patients who already have the … Continue reading

Posted in orange county breast cancer surgeon, orange county breast cancer surgery, Prevention, Research News | Tagged , , | Comments Off

As reported in leading media including this from the New York Times, the commissioner of the U. S. Food and Drug Administration revoked approval of the drug Avastin as a treatment for breast cancer, ruling in an emotional issue that … Continue reading

Posted in Clinical Trials, Research News | Tagged , | Comments Off

According to a report in the New York Times: The breast cancer drug letrozole reduces the chances that a woman’s cancer will return and improves her odds of survival to a greater degree than tamoxifen, a widely used estrogen blocker, … Continue reading

Posted in Chemotherapy, Research News | Tagged , , , , | Comments Off